Chemical Nature and Mechanism of Action
Chemically, sumatriptan is a synthetic tryptamine derivative. Its pharmacodynamics in migraine are unique, acting through a dual mechanism that affects both the vasculature and neurotransmission.
- Vascular component: The drug acts as a selective agonist of central $5-HT_{1D}$ receptors, which are localized primarily in cerebral blood vessels. During a migraine attack, excessive pulsation of these vessels occurs, causing severe pain. Receptor stimulation leads to marked vasoconstriction (narrowing of blood vessels). As a result, excessive pulsation is reduced, and the headache is relieved.
- Neuronal component: In addition to its vascular effects, sumatriptan stimulates presynaptic serotonin (5-HT) receptors. This inhibits the release of the specific pain mediator Substance P. Decreasing its concentration reliably suppresses pain signaling, providing a powerful analgesic effect.
Pharmacokinetics and Administration Routes
In clinical practice, three main routes of administration are used: oral (per os), subcutaneous, and intranasal. The choice of formulation depends on how quickly a clinical response is needed.
- Oral administration: Oral bioavailability is relatively low, at only about 14%. The therapeutic effect in this case begins to develop approximately 30 minutes after ingestion.
- Subcutaneous administration: If an acute attack requires immediate relief, the injection route is preferred. With subcutaneous administration, the drug acts three times faster—within just 10 minutes.
Regardless of the route of administration, the total duration of pharmacological action lasts for approximately 12 hours, allowing for effective control of the migraine attack.
Clinical Application and Safety Profile
The primary indication for sumatriptan is the acute treatment of migraine attacks. It is considered a drug of choice for patients resistant to standard non-narcotic analgesics (e.g., NSAIDs). However, its potent vasoconstrictive effect imposes serious limitations on its use.
Adverse effects:
- Cardiovascular system: There is a high risk of coronary vasospasm (this is the main limitation to its use).
- Other effects: Nausea, vomiting, systemic dizziness, fatigue, and taste disturbances are common.
Contraindications:
- Ischemic heart disease (IHD) — due to the critical risk of coronary vasospasm.
- Liver disease.
- Pregnancy and lactation.
- Age limitations: The drug is strictly contraindicated in pediatric practice (children under 18 years) and is not recommended for elderly patients (over 65 years).